Bedrosian Camille L

US insider· US
Sign in for alerts
  • REDUCEDT+30

    Amylyx Pharmaceuticals Inc · NASDAQ

    −7,947 sh · $256.0K

    Filed 14 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    Amylyx Pharmaceuticals Inc · NASDAQ

    −2,081 sh · $68.9K

    Filed 14 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Crinetics Pharmaceuticals In · NASDAQ

    −16,300 sh · $1.4M

    Filed 1 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Crinetics Pharmaceuticals In · NASDAQ

    −5,925 sh · $503.6K

    Filed 1 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Amylyx Pharmaceuticals Inc · NASDAQ

    +22,807 sh

    Filed 20 Aug 2026SEC Form 4view source